MedPath
TGA Approval

Idarubicin Injection 10 mg/10 mL (4) (405660)

405660

Idarubicin Injection 10 mg/10 mL (4)

Pfizer (Perth) Pty Ltd

March 3, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

idarubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.